Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Feasibility Pilot Study to Assess the Efficacy and Safety of the Use of Lazanda for Anxiolysis During Radiofrequency Nerve Ablation of Lumbar Facet Joints

NCT02571634 is registered in ClinicalTrials.gov with Defense and Veterans Center for Integrative Pain Management as lead sponsor.

NCT NCT02571634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02571634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Feasibility Pilot Study to Assess the Efficacy and Safety of the Use of Lazanda for Anxiolysis During Radiofrequency Nerve Ablation of Lumbar Facet Joints
Lead sponsor
Defense and Veterans Center for Integrative Pain Management
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2015
Completion date
January 31, 2016
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

minor procedural pain